Back
ESC Premium Access

Diminished preconditioning potential in the hearts from metabolic syndrome subjects can be partially restored by angiotensin-converting-enzyme inhibitor therapy

Session: Poster Session 7 - Coronary artery disease - Diagnosis, pharmacotherapy and revascularisation
Topic: Treatment, Other
Speaker: Doctor A. Yakubova (Leuven, BE)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Aziza Yakubova

Terumo Europe, Leuven (Belgium)
0 follower

16 more presentations in this session

Fibrinolytic therapy in patients with ST-segment elevation myocardial infarction: Accelerated versus standard Streptokinase infusion regimen; a randomized clinical study

Speaker: Associate Professor A. Bendary (Benha, EG)

Access
Abstract
Slides
Like
Thumbnail

Heart rate reduction with ivabradine restores endothelial function and reduces vascular stiffness in patients with chronic stable coronary artery disease

Speaker: Doctor A. Hohneck (Mannheim, DE)

Access
Abstract
Slides
Like
Thumbnail

Comparative efficacy of angiotensin converting enzyme inhibitor and angiotensin receptor blocker for patients with acute myocardial infarction and renal dysfunction

Speaker: Doctor J. Won (Gwangju, KR)

Access
Abstract
Like
Thumbnail

Therapeutic advantages of long-acting trimetazidine for the treatment of stable angina pectoris in routine clinical practice: findings from ODA trial

Speaker: Professor M. Glezer (Moscow, RU)

Access
Abstract
Like
Thumbnail

Mid-term outcomes of second-generation drug-eluting-stent implantation for left main coronary artery disease compare with first-generation drug-eluting-stent

Speaker: Doctor G. Yoshioka (Saga, JP)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 7 - Coronary artery disease - Diagnosis, pharmacotherapy and revascularisation

Speakers: Doctor A. Yakubova, Associate Professor A. Bendary, Doctor A. Hohneck, Doctor J. Won, Professor M. Glezer...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources